Alprostadil Patent Expiration
Alprostadil was first introduced by Pfizer Inc
Alprostadil Patents
Given below is the list of patents protecting Alprostadil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Caverject | US5741523 | Stabilized prostaglandin E1 |
Apr 21, 2015
(Expired) | Pfizer |
| Caverject Impulse | US5501673 | Injection cartridge |
Apr 16, 2013
(Expired) | Pfizer |
| Caverject Impulse | US5716338 | Dual-chamber type injection cartridge with bypass connection |
Feb 10, 2015
(Expired) | Pfizer |
| Muse | US5474535 | Dosage and inserter for treatment of erectile dysfunction |
Dec 12, 2012
(Expired) | Mylan Speciality Lp |
| Muse | US5886039 | Method and composition for treating erectile dysfunction |
Mar 23, 2016
(Expired) | Mylan Speciality Lp |
Try Our Curated Drug Screens
Alprostadil Generics
Several generic applications have been filed for Alprostadil. The first generic version for Alprostadil was by Hikma Pharmaceuticals Usa Inc and was approved on Jan 20, 1998. And the latest generic version is by Meitheal Pharmaceuticals Inc and was approved on Apr 30, 1999.
Given below is the list of companies who have filed for Alprostadil generic.
1. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Alprostadil. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/ML | injectable | Prescription | INJECTION | AP | Jan 20, 1998 |
2. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Alprostadil. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/ML | injectable | Prescription | INJECTION | AP | Apr 30, 1999 |